Susmed (TSE:4263) Total Stockholders Equity: 円4,108.9 Mil (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

TSE:4263 Susmed Inc TSE:4263
55 GF Score
Price 円424.00
GF Value 円903.78
Valuation Possible Value Trap
! 4 Warning Signs
View Full Analysis

What is Susmed Total Stockholders Equity?

Susmed TSE:4263 +0.24% 55 Total Stockholders Equity is 円4,108.9 Mil as of Mar. 2026. GuruFocus rates TSE:4263 with a GF Score™ of 55/100 and a GF Value™ of 円903.78 (Possible Value Trap). The stock has 4 warning signs investors should review.

Susmed's Total Stockholders Equity for the quarter that ended in Mar. 2026 was 円4,108.9 Mil. It refers to the net assets owned by shareholders. It does not include minority interest.

Total Stockholders Equity is used to calculate Book Value per Share. Susmed's Book Value per Share for the quarter that ended in Mar. 2026 was 円243.68. The ratio of a company's debt over equity can be used to measure how leveraged this company is. Susmed's Debt-to-Equity for the quarter that ended in Mar. 2026 was 0.00.

Susmed  (TSE:4263) Total Stockholders Equity Explanation

1. Total Stockholders Equity is used to calculate Book Value per Share.

Susmed's Book Value per Share for the quarter that ended in Mar. 2026 is

Book Value per Share=(Total Stockholders Equity-Preferred Stock)/Shares Outstanding (EOP)
=(4108.878-0)/16.862
=243.68

2. The ratio of a company's debt over equity can be used to measure how leveraged this company is.

Susmed's Debt-to-Equity for the quarter that ended in Mar. 2026 is

Debt-to-Equity=Total Debt / Total Stockholders Equity
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / Total Stockholders Equity
=(0 + 0) / 4108.878
=0.00

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Susmed Total Stockholders Equity Related Terms

Susmed Total Stockholders Equity Historical Data

* Premium members only.

The historical data trend for Susmed's Total Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Susmed Total Stockholders Equity Chart

Susmed Annual Data
Trend Jun20 Jun21 Jun22 Jun23 Jun24 Jun25 Jun26
Total Stockholders Equity
Get a 7-Day Free Trial 4,850.38 4,870.80 4,604.30 4,370.64 4,070.16

Susmed Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Total Stockholders Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 4,370.64 4,255.28 4,153.83 4,108.88 4,070.16
TSE:4263
55GF Score
Susmed Inc TSE:4263
Total Stockholders Equity is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
What does a Total Stockholders Equity of 円4,108.9 Mil mean?
Susmed (TSE:4263) has a Total Stockholders Equity of 円4,108.9 Mil as of Mar. 2026. The total amount of shareholder's equity as recorded on a company's balance sheet. View historical data for Susmed and its competitors.
Is Susmed's Total Stockholders Equity too high?
Susmed's current Total Stockholders Equity is 円4,108.9 Mil. Overall, Susmed has a GF Score™ of 55/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Susmed's Total Stockholders Equity compare to VEEV and BTSG?
Susmed's Total Stockholders Equity of 円4,108.9 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Stockholders Equity for a Healthcare Providers & Services company?
A good Total Stockholders Equity depends on the Healthcare Providers & Services industry context. However, Total Stockholders Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Stockholders Equity mean?
A high Total Stockholders Equity can signal that a stock is expensive relative to its fundamentals. The total amount of shareholder's equity as recorded on a company's balance sheet. View historical data for Susmed and its competitors. Susmed's current Total Stockholders Equity is 円4,108.9 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Susmed stock overvalued right now?
Based on GuruFocus' analysis, Susmed (TSE:4263) is currently considered Possible Value Trap. The stock's GF Value™ is 円903.78, compared to a current price of 円424.00 — trading 53.1% below its estimated fair value. The current Total Stockholders Equity is 円4,108.9 Mil. Susmed's overall GF Score™ is 55/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Stockholders Equity calculated?
Total Stockholders Equity is calculated from a company's financial statements. For Susmed (TSE:4263), the current Total Stockholders Equity is 円4,108.9 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Susmed (TSE:4263) Overvalued in 2026?

Based on GuruFocus' analysis, Susmed stock appears to be undervalued. The current stock price of 円424.00 is trading 53.1% below its estimated GF Value™ of 円903.78. GuruFocus considers Susmed to be Possible Value Trap.

Key valuation signals for TSE:4263:

  • Total Stockholders Equity: 円4,108.9 Mil
  • GF Value™: 円903.78 vs. price of 円424.00 (53.1% below fair value)
  • GF Score™: 55/100 with 4 warning signs

No single metric tells the full story. See the TSE:4263 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Susmed Business Description

Address 3-7-2 Nihonbashi Honcho, 10th Floor, MFPR Nihonbashi Honcho Building, Chuo-ku, Tokyo, JPN, 103-0023
Susmed Inc is engaged in the development of therapeutic smartphone apps and digital solutions to streamline clinical trials. It is currently developing therapeutic apps for patients with insomnia, breast cancer, kidney disease, and other conditions. In addition, it has developed Susumed System, which uses a proprietary blockchain technology to ensure the reliability of clinical trial data, and can reduce the manpower and costs allocated to clinical trials. The company's reportable segments are: the DTx Product Business, which derives maximum revenue, and consists of the development of therapeutic apps; and the DTx Platform Business, which provides general-purpose clinical trial systems and machine learning automated analysis systems.
55GF Score

Get the complete analysis for TSE:4263

Total Stockholders Equity is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

円424.00
Price
円903.78
GF Value